Easy Access and Express Report Delivery Service
Highlights The global Multiplex Immunofluorescence Assay market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. North American market for Multiplex Immunofluorescence Assay is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Asia-Pacific market for Multiplex Immunofluorescence Assay is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. The major global companies of Multiplex Immunofluorescence Assay include Fluidigm and Akoya Biosciences etc. In 2022, the world's top three vendors accounted for approximately % of the revenue. The global market for Multiplex Immunofluorescence Assay in Academic and Research Institution is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Material, which accounted for % of the global market of Multiplex Immunofluorescence Assay in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Multiplex Immunofluorescence Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Immunofluorescence Assay. The Multiplex Immunofluorescence Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Multiplex Immunofluorescence Assay market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Multiplex Immunofluorescence Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Multiplex Immunofluorescence Assay by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 Material 1.2.3 Equipment 1.2.4 Software and Service 2.3 Multiplex Immunofluorescence Assay by Application 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) 2.3.2 Academic and Research Institution 2.3.3 Hospital 2.3.4 Others 2.4 Assumptions and Limitations 3 Multiplex Immunofluorescence Assay Breakdown Data by Type 3.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Type (2018-2023) 3.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Type (2023-2028) 4 Multiplex Immunofluorescence Assay Breakdown Data by Application 4.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Application (2018-2023) 4.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Application (2018-2023) 5 Global Growth Trends 5.1 Global Multiplex Immunofluorescence Assay Market Perspective (2018-2029) 5.2 Global Multiplex Immunofluorescence Assay Growth Trends by Region 5.2.1 Global Multiplex Immunofluorescence Assay Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Multiplex Immunofluorescence Assay Historic Market Size by Region (2018-2023) 5.2.3 Multiplex Immunofluorescence Assay Forecasted Market Size by Region (2024-2029) 5.3 Multiplex Immunofluorescence Assay Market Dynamics 5.3.1 Multiplex Immunofluorescence Assay Industry Trends 5.3.2 Multiplex Immunofluorescence Assay Market Drivers 5.3.3 Multiplex Immunofluorescence Assay Market Challenges 5.3.4 Multiplex Immunofluorescence Assay Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue 6.1.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue (2018-2023) 6.1.2 Global Multiplex Immunofluorescence Assay Revenue Market Share by Players (2018-2023) 6.2 Global Multiplex Immunofluorescence Assay Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Multiplex Immunofluorescence Assay Head office and Area Served 6.4 Global Multiplex Immunofluorescence Assay Players, Product Type & Application 6.5 Global Multiplex Immunofluorescence Assay Players, Date of Enter into This Industry 6.6 Global Multiplex Immunofluorescence Assay Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Multiplex Immunofluorescence Assay Market Size (2018-2029) 7.2 North America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) 7.4 North America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Multiplex Immunofluorescence Assay Market Size (2018-2029) 8.2 Europe Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) 8.4 Europe Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Multiplex Immunofluorescence Assay Market Size (2018-2029) 9.2 Asia-Pacific Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) 9.4 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Multiplex Immunofluorescence Assay Market Size (2018-2029) 10.2 Latin America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) 10.4 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Multiplex Immunofluorescence Assay Market Size (2018-2029) 11.2 Middle East & Africa Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) 11.4 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 Fluidigm 11.1.1 Fluidigm Company Detail 11.1.2 Fluidigm Business Overview 11.1.3 Fluidigm Multiplex Immunofluorescence Assay Introduction 11.1.4 Fluidigm Revenue in Multiplex Immunofluorescence Assay Business (2017-2022) 11.1.5 Fluidigm Recent Development 11.2 Akoya Biosciences 11.2.1 Akoya Biosciences Company Detail 11.2.2 Akoya Biosciences Business Overview 11.2.3 Akoya Biosciences Multiplex Immunofluorescence Assay Introduction 11.2.4 Akoya Biosciences Revenue in Multiplex Immunofluorescence Assay Business (2017-2022) 11.2.5 Akoya Biosciences Recent Development 13 Report Conclusion 14 Disclaimer